ATE427311T1 - (r/s) rifamycin-derivate, ihre herstellung und pharmazeutische zusammensetzungen - Google Patents

(r/s) rifamycin-derivate, ihre herstellung und pharmazeutische zusammensetzungen

Info

Publication number
ATE427311T1
ATE427311T1 AT05791212T AT05791212T ATE427311T1 AT E427311 T1 ATE427311 T1 AT E427311T1 AT 05791212 T AT05791212 T AT 05791212T AT 05791212 T AT05791212 T AT 05791212T AT E427311 T1 ATE427311 T1 AT E427311T1
Authority
AT
Austria
Prior art keywords
sub
rifamycin derivatives
preparation
humans
pharmaceutical compositions
Prior art date
Application number
AT05791212T
Other languages
English (en)
Inventor
Charles Ding
Zhenkun Ma
Jing Li
Susan Harran
Yong He
Keith Minor
In Kim
Jamie Longgood
Yafei Jin
Keith Combrink
Original Assignee
Cumbre Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cumbre Pharmaceuticals Inc filed Critical Cumbre Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE427311T1 publication Critical patent/ATE427311T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT05791212T 2004-07-22 2005-07-21 (r/s) rifamycin-derivate, ihre herstellung und pharmazeutische zusammensetzungen ATE427311T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59019004P 2004-07-22 2004-07-22

Publications (1)

Publication Number Publication Date
ATE427311T1 true ATE427311T1 (de) 2009-04-15

Family

ID=35355764

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05791212T ATE427311T1 (de) 2004-07-22 2005-07-21 (r/s) rifamycin-derivate, ihre herstellung und pharmazeutische zusammensetzungen

Country Status (11)

Country Link
US (2) US7226931B2 (de)
EP (2) EP1768987B1 (de)
JP (2) JP5153329B2 (de)
CN (2) CN101031572B (de)
AT (1) ATE427311T1 (de)
AU (1) AU2005267054B2 (de)
CA (2) CA2574301C (de)
DE (1) DE602005013671D1 (de)
HK (1) HK1102808A1 (de)
NZ (1) NZ565002A (de)
WO (2) WO2006012443A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528189A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
JP2006528190A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
JP2007513869A (ja) * 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
WO2005056526A1 (ja) 2003-12-12 2005-06-23 Daiichi Pharmaceutical Co., Ltd. 光学活性なシクロプロピルアミン誘導体の製造中間体およびその製造法
JP2008505124A (ja) * 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
GB0505909D0 (en) * 2005-03-23 2005-04-27 Univ Leeds Formulations
EA016059B1 (ru) 2005-08-11 2012-01-30 Тарганта Терапьютикс Инк. Фосфонированные рифамицины и их применение для профилактики и лечения костных и суставных инфекций
WO2007021683A2 (en) 2005-08-15 2007-02-22 Janssen Pharmaceutica N.V. Human cell clones useful for functional analyses of the biological activity of an endogeneous urotensin ii receptor and uses thereof
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
TWI454262B (zh) 2006-11-02 2014-10-01 Targacept Inc 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
WO2009064792A1 (en) * 2007-11-16 2009-05-22 Cumbre Pharmaceuticals Inc. Quinolone carboxylic acid-substituted rifamycin derivatives
CN104650114A (zh) 2008-02-25 2015-05-27 萨利克斯药品有限公司 利福昔明的多种形式及其用途
US8486956B2 (en) * 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
EP2257549A1 (de) * 2008-03-05 2010-12-08 Targacept Inc. Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide
US8278313B2 (en) * 2008-03-11 2012-10-02 Abbott Laboratories Macrocyclic spiro pyrimidine derivatives
WO2010019511A2 (en) 2008-08-13 2010-02-18 Targanta Therapeutics Corp. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
CN101875658B (zh) * 2009-04-28 2013-01-09 上海药明康德新药开发有限公司 3-羰基-2,8-二氮杂螺[4.5] 癸烷-8-羧酸叔丁酯的制备方法
AU2010310595B2 (en) 2009-10-23 2015-07-16 Janssen Pharmaceutica Nv Disubstituted octahy - dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
CA2801074A1 (en) 2010-06-04 2011-12-08 Albany Molecular Research, Inc. Glycine transporter-1 inhibitors, methods of making them, and uses thereof
MX2015001963A (es) * 2012-08-13 2015-06-04 Adipharm Ead Formulaciones farmaceuticas que contienen derivados con 3-(4-cinamil-1-piperazinil)-amino de 3-formilrifamicinas sv y 3-formilrifamicina s y un proceso para su preparacion.
CN104955457A (zh) * 2012-09-12 2015-09-30 萨利克斯药品公司 给予利福昔明而不产生抗生素耐药性的方法
CN103709177B (zh) * 2013-12-20 2016-02-24 武汉工程大学 利福霉素类沃尼妙林杂合抗生素及其制备方法
CN104710439B (zh) * 2015-03-06 2017-11-07 丹诺医药(苏州）有限公司 一种利福霉素‑喹嗪酮双靶标分子的晶型i及其制备方法
CN104628745B (zh) * 2015-03-06 2017-03-08 丹诺医药(苏州）有限公司 一种利福霉素‑喹嗪酮双靶标分子的富马酸盐及其制备方法
HUE058759T2 (hu) 2016-03-10 2022-09-28 Janssen Pharmaceutica Nv Módszerek depresszió kezelésére orexin-2 receptor antagonisták alkalmazásával
CN105879009A (zh) * 2016-04-18 2016-08-24 丹诺医药(苏州）有限公司 一种用于治疗革兰氏阴性菌感染的抗菌药物组合物
AU2017279027A1 (en) 2016-06-08 2018-12-20 Glaxosmithkline Intellectual Property Development Limited Chemical Compounds
CN106902116B (zh) * 2017-02-28 2021-03-23 丹诺医药(苏州）有限公司 一种利福霉素-喹嗪酮双靶标分子的应用
CN106822125A (zh) * 2017-02-28 2017-06-13 丹诺医药(苏州）有限公司 一种利福霉素‑喹嗪酮双靶标分子的新用途
CN109251258B (zh) * 2017-07-13 2021-06-01 中国石油天然气股份有限公司 宽分布聚丙烯催化组分、组分制备方法及其催化剂
WO2019027860A1 (en) * 2017-08-01 2019-02-07 Boehringer Ingelheim International Gmbh INTERMEDIATE COMPOUNDS AND METHODS
CN108310393A (zh) * 2018-02-12 2018-07-24 丹诺医药(苏州）有限公司 一种利福霉素-喹嗪酮偶联分子的应用
CN109464673A (zh) * 2019-01-08 2019-03-15 丹诺医药(苏州）有限公司 利福霉素-喹嗪酮偶联分子及其盐的应用和制剂
CN109529045B (zh) * 2019-01-08 2021-05-18 丹诺医药(苏州）有限公司 利福霉素-喹嗪酮偶联分子及其药学上可接受的盐的应用
CN109942474B (zh) * 2019-03-04 2020-09-18 华中科技大学 一种邻叠氮-肼类化合物及其制备方法
CN115501230B (zh) * 2022-08-05 2023-11-21 丹诺医药(苏州）有限公司 利福霉素-喹嗪酮偶联分子软膏剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2088870T3 (es) * 1988-03-18 1996-10-01 Kanegafuchi Chemical Ind Un derivado de benzoxazinorrifamicina sustituida, un procedimiento para preparar el mismo y un agente antibacteriano que contiene el mismo.
DK0700399T3 (da) 1993-05-24 2001-11-26 Lepetit Spa Derivater i 36-stilling af rifamyciner og anvendelse af sådanne som antimikrobemidler
EP1453837A4 (de) * 2001-11-21 2007-11-07 Activbiotics Inc Zielgerichtete therapeutika und deren anwendungen
WO2005070941A1 (en) 2004-01-13 2005-08-04 Cumbre Pharmaceuticals Inc. Rifamycin imino derivatives effective against drug-resistant microbes
US7247634B2 (en) 2004-01-13 2007-07-24 Cumbre Pharmaceuticals Inc. Rifamycin derivatives effective against drug-resistant microbes

Also Published As

Publication number Publication date
CA2574301A1 (en) 2006-02-02
WO2006012443A1 (en) 2006-02-02
CA2574301C (en) 2013-09-10
HK1102808A1 (en) 2007-12-07
NZ565002A (en) 2009-08-28
AU2005267054B2 (en) 2011-06-23
CA2574307A1 (en) 2006-02-02
EP1768987B1 (de) 2009-04-01
US7229996B2 (en) 2007-06-12
JP2008507549A (ja) 2008-03-13
JP2008507548A (ja) 2008-03-13
AU2005267054A1 (en) 2006-02-02
DE602005013671D1 (de) 2009-05-14
CN101065385A (zh) 2007-10-31
WO2006012470A1 (en) 2006-02-02
US20060019985A1 (en) 2006-01-26
CN101031572B (zh) 2010-12-08
US20060019986A1 (en) 2006-01-26
JP5236944B2 (ja) 2013-07-17
JP5153329B2 (ja) 2013-02-27
EP1781670A1 (de) 2007-05-09
CN101031572A (zh) 2007-09-05
EP1768987A1 (de) 2007-04-04
US7226931B2 (en) 2007-06-05

Similar Documents

Publication Publication Date Title
ATE427311T1 (de) (r/s) rifamycin-derivate, ihre herstellung und pharmazeutische zusammensetzungen
AUPR213700A0 (en) Antiviral agents
IL204621A (en) Amino Acid Derivatives - γ - In bicycles preparations containing them and their uses
CO5280078A1 (es) Compuestos
EP2266623A3 (de) Prodrugs mit neuen biospaltbaren Verbindern
WO2008108386A1 (ja) 医薬組成物
AU2003222106A1 (en) Thiopene-based tricyclic compounds and pharmaceutical compositions comprising same
WO2010032147A3 (en) Hydroxamic acid derivatives useful as antibacterial agents
WO2003010135A1 (fr) Nouveaux derives de l'acide phenylpropionique
EP1813270A4 (de) Proteininhibitoren der hsp90-familie
DE60044369D1 (de) Synthetisches oligomannosid, seine herstellung und verwendung
MY140325A (en) Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
WO2002020525A3 (en) Protein tyrosine phosphatase inhibitor
TW200745153A (en) Trehalose compound and pharmaceutical comprising the compound
MY140666A (en) Biotinylated hexadecasaccharides, preparation and use thereof
HRP20060023A2 (en) Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions
TR200200550T2 (tr) Piruvat dehidrojenaz aktivitesini yükselten ikameli n-fenil 2-hidroksi -2- metil -3,3,3- triflüoropropanamid türevleri.
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
AU2003294031A1 (en) Dust-free pigment compositions obtainable by spray-drying
RS20050837A (en) NEW 3-DECLADINOSYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES OF 9-DEOX-9-DIHYDRO-9a-AZA-9A- HOMOERYTHROMYCIN A NEW 3- DECLADINOSYL 9A-N-CARBAMOYL AND -A- N-THIOCARBAMOYL DERIVATIVES OF 9- DEOX-9-DIHYDRO-9A-AZA-9A- HOMOERYTHROMYCIN A
NO20015346D0 (no) Haloderivater av 9-deoksy-9A-aza-9A-homoerytromycin A
JP2008519093A5 (de)
PT1351942E (pt) Novos derivados da 2,3-benzodiazepina e composicoes farmaceuticas contendo os mesmos como o ingrediente activo
WO2006075255A3 (en) Anti-inflamatory macrolide conjugates
ATE244226T1 (de) Polyhydroxypyrazinederivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties